Cargando...
Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
AIM: To investigate the clinical utility of serum annexin A2 (ANXA2) as a diagnostic marker for early hepatocellular carcinoma (HCC). METHODS: This study was performed in HCC Clinic of Ain Shams University Hospitals, Cairo, Egypt and included: Group 1: Fifty patients with early stage HCC (Barcelona...
Gardado en:
| Publicado en: | World J Hepatol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5368624/ https://ncbi.nlm.nih.gov/pubmed/28396717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v9.i9.469 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|